Use of Combination Therapy in IBD

被引：2
|
作者：
Kaplan, Gil [1 ]
Panaccione, Remo [1 ]
机构：
[1] Univ Calgary, Inflammatory Bowel Dis Clin, Div Gastroenterol, Dept Med, Calgary, AB T2N 1N4, Canada
来源：
INFLAMMATORY BOWEL DISEASES | 2008年 / 14卷
关键词：
D O I：
10.1002/ibd.20688
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S219 / S221
页数：3
相关论文
共 50 条
  • [41] The Use of Appropriate Medical Therapy in an Underserved Population with Inflammatory Bowel Disease (IBD)
    Joseph, Neal
    Sussman, Daniel
    Clark, John
    Deshpande, Amar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S474 - S474
  • [42] De-Novo IBD After Kidney Transplant: Use of Vedolizumab Therapy
    Modi, Zeel N.
    Trivedi, Itishree
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S2153 - S2153
  • [43] A population based study of the use of steroids and immunomodulator therapy by IBD patients.
    Bernstein, CN
    Metge, C
    Blanchard, JF
    Peterson, SP
    GASTROENTEROLOGY, 2000, 118 (04) : A784 - A784
  • [44] THIOPURINE USE IN IBD IS ASSOCIATED WITH A STRONG IMPACT ON B CELLS PROVIDING FURTHER EXPLANATION FOR INCREASED EFFICACY OF ITS COMBINATION THERAPY WITH ANTI-TNF
    Kosoy, Roman
    Ungaro, Ryan C.
    Huang, Ruiqi
    Kim-Schulze, Seunghee
    Rahman, Adeeb
    Mehandru, Saurabh
    Perrigoue, Jacqueline
    Merad, Miriam
    Prime, Aleksandar Stojmirovic
    Friedman, Joshua
    Schadt, Eric E.
    Dubinsky, Marla C.
    Sands, Bruce E.
    Kasarskis, Andrew
    Colombel, Jean Frederic
    Argmann, Carmen A.
    Suarez-Farinas, Mayte
    GASTROENTEROLOGY, 2020, 158 (06) : S53 - S54
  • [45] Cytokine Storm in IBD: Balancing the Risks of IBD Medical Therapy
    Rodriguez-Lago, Iago
    Alonso-Galan, Horacio
    Luis Cabriada, Jose
    GASTROENTEROLOGY, 2021, 160 (05) : 1878 - 1880
  • [46] IBD IN 2017 Development of therapy for and prediction of IBD - getting personal
    Atreya, Raja
    Siegmund, Britta
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (02) : 73 - 74
  • [47] Managing the risks of IBD therapy
    Seow C.H.
    De Silva S.
    Kaplan G.G.
    Devlin S.M.
    Ghosh S.
    Panaccione R.
    Current Gastroenterology Reports, 2009, 11 (6) : 509 - 517
  • [48] Thiopurine metabolite monitoring and allopurinol combination therapy: current utilisation and influence on Australian gastroenterology IBD practice
    Sze, K. C. P.
    Ng, W. S. W.
    Connor, S. J.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S194 - S194
  • [49] Combination therapy with an immunomodulator and anti-INFa agent improves bone mineral density in IBD patients
    Krajcovicova, Anna
    Hlavaty, Tibor
    Killinger, Zdenko
    Miznerova, Ema
    Toth, Jozef
    Letkovsky, Juraj
    Nevidanska, Monika
    Cierny, Daniel
    Koller, Tomas
    Zelinkova, Zuzana
    Huorka, Martin
    Payer, Juraj
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (12): : 1693 - 1701
  • [50] Elafin—a potential IBD therapy
    Claire Greenhill
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 (12) : 686 - 686
12345